HK1004910A1 - Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients - Google Patents

Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients

Info

Publication number
HK1004910A1
HK1004910A1 HK98104022A HK98104022A HK1004910A1 HK 1004910 A1 HK1004910 A1 HK 1004910A1 HK 98104022 A HK98104022 A HK 98104022A HK 98104022 A HK98104022 A HK 98104022A HK 1004910 A1 HK1004910 A1 HK 1004910A1
Authority
HK
Hong Kong
Prior art keywords
carnitine
acyl
aids
carnitines
related syndromes
Prior art date
Application number
HK98104022A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1004910A1 publication Critical patent/HK1004910A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98104022A 1992-09-24 1998-05-09 Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients HK1004910A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920693A IT1258491B (it) 1992-09-24 1992-09-24 Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.

Publications (1)

Publication Number Publication Date
HK1004910A1 true HK1004910A1 (en) 1998-12-11

Family

ID=11401203

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104022A HK1004910A1 (en) 1992-09-24 1998-05-09 Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients

Country Status (12)

Country Link
US (1) US5631288A (fr)
EP (1) EP0590355B1 (fr)
JP (1) JPH06227983A (fr)
KR (1) KR0136559B1 (fr)
AT (1) ATE160090T1 (fr)
DE (1) DE69315162T2 (fr)
DK (1) DK0590355T3 (fr)
ES (1) ES2110551T3 (fr)
GR (1) GR3025372T3 (fr)
HK (1) HK1004910A1 (fr)
IT (1) IT1258491B (fr)
ZA (1) ZA936300B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000137A1 (fr) * 1993-06-21 1995-01-05 Bernardini, Attilio Utilisation de l'acylcarnitine pour le traitement de maladies liees au sida
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20080119386A1 (en) * 2006-11-22 2008-05-22 Carl Germano Nutritional formula for athletes' recovery
CA2681158C (fr) 2007-03-13 2018-09-18 Nutrition 21, Inc. Procedes et compositions utilises pour la liberation prolongee de chrome
WO2009002867A2 (fr) 2007-06-26 2008-12-31 Nutrition 21, Inc. Forme posologique à unités multiples contenant un agent thérapeutique en combinaison avec un complément alimentaire
EP3413900A1 (fr) 2016-02-11 2018-12-19 Nutrition 21, LLC Compositions à base de chrome pour améliorer la santé et la forme physique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1143214B (it) * 1981-07-09 1986-10-22 Sigma Tau Ind Farmaceuti Acil derivato della carnitina quale immunomodulatore
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease

Also Published As

Publication number Publication date
DE69315162T2 (de) 1998-03-12
ITRM920693A0 (it) 1992-09-24
JPH06227983A (ja) 1994-08-16
EP0590355B1 (fr) 1997-11-12
KR0136559B1 (ko) 1998-04-25
DE69315162D1 (de) 1997-12-18
ITRM920693A1 (it) 1994-03-24
DK0590355T3 (da) 1998-03-02
EP0590355A1 (fr) 1994-04-06
ATE160090T1 (de) 1997-11-15
IT1258491B (it) 1996-02-26
KR940006576A (ko) 1994-04-25
US5631288A (en) 1997-05-20
GR3025372T3 (en) 1998-02-27
ES2110551T3 (es) 1998-02-16
ZA936300B (en) 1995-02-27

Similar Documents

Publication Publication Date Title
GB8712073D0 (en) Medicament
IE870194L (en) Use of lithium compounds in senile dementia
GB2285219B (en) Use of norastemizole for the treatment of allergic disorders
GR3025372T3 (en) Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients
EP0414772A4 (en) Method for treating acne
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
ZA895345B (en) Therapeutic compounds
LU90791I2 (fr) Potentialisateur d'effets antineoplasique et agent antineoplasique
AU670491C (en) Pharmaceutical for the treatment of skin disorders
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
GR3022205T3 (en) New derivatives of physostigmine, their use and pharmaceutical formulations containing them
HK175896A (en) Medicament for the treatment of cardiac insufficiency
EP0642338A1 (fr) UTILISATION DE (E)-2-(p-FLUOROPHENETHYLE)-3-FLUOROALLYLAMINE DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER.
GR3003880T3 (fr)

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)